April 8, 2026

Science Chronicle

A Science and Technology Blog

April 8, 2026

Science Chronicle

A Science and Technology Blog

CoronavirusCOVID-19omicronPublic HealthSARS-CoV-2

Variants do not always evolve to become less virulent

Since transmission begins before symptoms set in and the disease becomes severe, its characteristic is decoupled from disease

Read More
Communicable diseaseCOVID-19omicronPublic HealthSARS-CoV-2

Why Omicron sub-lineage BA.2 spreads faster than BA.1 

A few studies are now discovering that BA.2 sub-lineage has even higher propensity than BA.1 to spread among people

Read More
COVID-19Human challenge studiesResearchSARS-CoV-2

Human challenge study finds high viral shedding in asymptomatic people

The study first detected the virus in the throat and the nose two days before peak symptoms showed up

Read More
Communicable diseaseomicronPublic HealthSARS-CoV-2Testing

IGIB develops future-proof primers, kits for RT-PCR test for SARS-CoV-2

The pool of primers has been developed to target regions of the virus which are unlikely to undergo mutations

Read More
COVID-19omicronPublic HealthSARS-CoV-2

Faster spread of Omicron is not due to higher viral load

Omicron has replaced the Delta variant, which was considered highly transmissible, in almost every country across the world

Read More
Communicable diseaseCOVID-19Public HealthSARS-CoV-2Testing

COVID-19: The revised testing strategy of the ICMR

The story so far: With the highly transmissive Omicron variant now recorded in most States, and given the mild symptoms seen

Read More
HealthXenotransplantation

Will the pig-to-human heart operation lead to a new approach to organ transplantation?

The story so far: On January 7, David Bennett, a 57-year-old from Baltimore, Maryland, U.S. became the first person to receive a

Read More
Clinical trialCommunicable diseaseCOVID-19Public HealthSARS-CoV-2Vaccines

COVID-19: Covaxin booster increases neutralising antibodies, study finds

The control arm of the study had 93 participants and the intervention arm had 91 participants, but most of these people were under 55 years

Read More
Communicable diseaseCOVID-19Public HealthSARS-CoV-2Vaccines

COVID-19: Booster doses only mitigate disease severity, do not fully prevent infection

Though 90.8 million people above 60 years, 9.7 million health-care workers and nearly 17 million frontline workers have received the

Read More
Clinical trialCommunicable diseaseCOVID-19ImmunisationVaccines

COVID-19: Are there clinical trial data to support a homologous vaccine booster?

This means those who have received Covishield as their first and second dose will receive Covishield as their third dose.

Read More
COVID-19Public HealthSARS-CoV-2

Conflicting signals from drug regulator, COVID-19 national task force

“Considering the emergency and unmet medical need in Covid-19, the SEC on December 27 recommended for grant of permission to

Read More
Communicable diseaseCOVID-19omicronPublic HealthSARS-CoV-2

COVID-19: Even if mild, Omicron variant can overwhelming health-care settings

Huge percentage of the population in India got infected when the Delta variant raged through the country. Studies from other

Read More
Communicable diseasePublic HealthVaccinesWorld Health Organisation

Does Covaxin have WHO’s approval for use in children?

While clearly stating that teenagers aged 15 years or more (all those whose birth year is 2007 or before) will

Read More